Translations:Ethyl eicosapentaenoic acid/21/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,162 edits
Importing a new version from external source
 
(No difference)

Latest revision as of 19:16, 15 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Ethyl eicosapentaenoic acid)
==History==
In July 2012, the US [[Food and Drug Administration]] (FDA) approved ethyl eicosapentaenoic acid (E-EPA) for severe [[hypertriglyceridemia]] as an adjunct to dietary measures; [[Amarin Corporation]] had developed the drug. Amarin Corporation challenged the FDA's authority to limit its ability to market the drug for [[off-label use]] and won its case on appeal in 2012, changing the way the FDA regulates the marketing of medication.

History

In July 2012, the US Food and Drug Administration (FDA) approved ethyl eicosapentaenoic acid (E-EPA) for severe hypertriglyceridemia as an adjunct to dietary measures; Amarin Corporation had developed the drug. Amarin Corporation challenged the FDA's authority to limit its ability to market the drug for off-label use and won its case on appeal in 2012, changing the way the FDA regulates the marketing of medication.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Ethyl_eicosapentaenoic_acid/21/en&oldid=139669"